Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Case Report: Multiple sclerosis and Neurofibromatosis type 1: a rare comorbidity.
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Mimicking Central Nervous System Infection in an Adolescent: A Case Report.
Disease Course After Anti-CD20 Discontinuation in Secondary Progressive Multiple Sclerosis-A Multicenter Long-Term Longitudinal Study.
Portable Ultra-Low Field MRI Deep-Learning Algorithms for White Matter Lesion Segmentation Improve Accuracy and Reflect Clinical Disability in Multiple Sclerosis.
Unusual Sequential Development of Multiple Sclerosis, Thymoma, Myasthenia, and Lymphoma in the Same Patient.
Coexistence of Neuromyelitis Optica Spectrum Disorder and Proliferative Lupus Nephritis: A Rare Case Report.
New insights on microglial lysosomal acidification: A therapeutic target of neurodegenerative diseases.
Age-Associated B Cells: Origins, Regulation, and Tissue-Specific Pathogenic Contributions in Autoimmune, Metabolic, and Neurological Diseases.
Nonsystemic Vasculitic Neuropathy Presenting as Inflammatory Demyelinating Polyradiculoneuropathy.
Glymphatic System Function and Cognition: Converging Evidence from DTI-ALPS Imaging - A Narrative Review.
Taking another look: LBSL diagnosed in adulthood masquerading as multiple sclerosis.
Real-world Roche Elecsys and Fujirebio Lumipulse inter-platform comparability and clinical validation of plasma neurofilament light chain in multiple sclerosis.
Amyloid-β suppresses oligodendrocyte differentiation in adult oligodendrocyte precursor cells (OPCs), with inflammatory gene changes distinguishing it from developmental OPCs.
Recurrent Myelin Oligodendrocyte Glycoprotein Antibody-Positive Aseptic Meningitis at the Identical Site in a Child: Leptomeningeal Enhancement Detected by Contrast-Enhanced FLAIR Imaging.
Baseline Oculomotor Parameters Are Prospectively Associated with Cognitive Processing Speed at 6-Year Follow-Up in Multiple Sclerosis: An Exploratory Cohort Study.
Importance of physiotherapy and occupational therapy according to people with multiple sclerosis-results from an online survey.
Complement C5 inhibitors as add-on rescue treatment in severe AQP4-antibody neuromyelitis optica spectrum disorder attacks: a case series and literature review.
Self-mastery buffers associations between stressful life events and mental quality of life and fatigue in people living with multiple sclerosis.
Refined single-cell profiling captures a CCR5 CD4 cytotoxic T-cell precursor in multiple sclerosis.
Learning from authentic patient narratives in nursing education using Gibbs' Reflective Cycle: A qualitative study using reflexive thematic analysis.
High-dose Vitamin D and Non-Skeletal Health.
The association between depressive symptoms and sleep quality in patients with multiple sclerosis: a systematic review and meta-analysis.
Inhibiting fear memory recall-induced oligodendrogenesis rescues PTSD-like behaviors.
Correlation of serum glial fibrillary acidic protein (GFAP) and soluble triggering receptor expressed on myeloid cells-2 (sTREM-2) levels with disability and clinical characteristics in multiple sclerosis.
Ocrelizumab-Induced Brain Volume Dynamics in Relapsing-Remitting Multiple Sclerosis.
Pages
« first
‹ previous
…
1039
1040
1041
1042
1043
1044
1045
1046
1047
…
next ›
last »